Clear Street’s Veraxa Biotech Warrants VRXAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.2K Buy
485,658
+300
+0.1% +$31 ﹤0.01% 1117
2026
Q2
$53.5K Buy
+485,358
New +$85.6K ﹤0.01% 956

Other funds holding VRXAW

Clear Street's VRXAW Position: Q3 2026 in Review

Clear Street increased its Veraxa Biotech Warrants (VRXAW) stake by 0.06% in Q3 2026, buying an estimated $31 and bringing the position to 485,658 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Clear Street first reported a position in VRXAW in Q2 2026 and has held it in 2 quarters since. The position peaked at $53.5K in Q2 2026. 29 funds tracked by Wall St. Rank hold VRXAW as of Q3 2026.

  • Clear Street held 485,658 shares of Veraxa Biotech Warrants worth $29.2K as of Q3 2026.
  • Clear Street bought 300 Veraxa Biotech Warrants shares in Q3 2026, an estimated $31.
  • Veraxa Biotech Warrants made up ﹤0.01% of Clear Street's portfolio in Q3 2026, its #1117 holding.
  • Clear Street first reported a position in Veraxa Biotech Warrants in Q2 2026 and has held it in 2 quarters since.
  • Clear Street's Veraxa Biotech Warrants position peaked at $53.5K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Veraxa Biotech Warrants as of Q3 2026.

Based on Clear Street's 13F filing for Q3 2026, filed 16 Nov 2026.